tirzepatide heart health and Cardiovascular Health: Protect Your While You Lose Weight Tirzepatide for Heart Failure with

If workweek lunches are your downfall, Sunday evening injection keeps Tuesday and Wednesday well covered

Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants

Candidates for supervised discontinuation: Maintained goal weight on a stable dose for 12 or more months Lost weight primarily through combined medication and lifestyle change (not medication alone) Consume 1.2 to 1.6 g protein per kg body weight daily Perform resistance training 3 or more times per week Sleep 7 or more hours nightly with good sleep architecture Have a BMI at goal of 25 or higher (patients who drop into the low-normal range have less metabolic buffer) No history of binge eating disorder or significant emotional eating patterns Even with this profile, the SURMOUNT-4 data suggests that roughly half of patients will regain meaningful weight within 12 months of stopping (Aronne et al., JAMA 2024)

1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss

Successful oral formulation would eliminate the injection barrier that limits patient acceptance of incretin therapies

A 5-ounce glass of dry wine or 1.5 ounces of distilled spirits contains far fewer calories than sweet cocktails or regular beer